SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AVANT Immunotherapeutics Inc. (Nasdaq: AVAN)
AVAN 10.040.0%Jun 12 9:41 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: 613 who wrote (385)2/21/2002 9:21:13 AM
From: rrufff  Read Replies (1) of 513
 
Looks like a few shorts trying to sneak out early. We're hitting trades at $1.20. Anyone short here has to realize if they wait, they risk a major rebound.

This is a real company with real things in the pipeline and enough cash to take it to the next step, be that sucess with at least one major line or, IMO, a take-over by a big pharma company.

The last shorters here might be trying to hold on the last 20 cents, but may take a huge hit in the meantime if they can't get out once it starts running.

Just my opinion of short term.

Long term - this has a much better risk/reward picture. It was comfortable in the 3.75-4.20 range. So, now give the company a hit because of yesterday's news of e.g. 25%, which I think is high. So it should be selling, in a bad market before any successes at perhaps $3. If one of its vaccines hits it big, then you'll see the massive share prices the ANALysts and touts give this.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext